Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-21

Clinical Trial Update: MetfOrmin BenefIts Lower Extremities With Intermittent Claudication [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating whether metformin provides benefit for patients with intermittent claudication; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • metformin (metformin)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Intermittent Claudication | Phase 3 | Status: RECRUITING